Biodefense Market 2018

Wiseguyreports.Com adds “Biodefense Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Report Details:

This report provides in depth study of “Biodefense Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Biodefense Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

The global Biodefense market is valued at 850 million US$ in 2017 and will reach 1500 million US$ by the end of 2025, growing at a CAGR of 7.3% during 2018-2025.

This report studies the global Biodefense market status and forecast, categorizes the global Biodefense market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.

In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack. 

USA is still the largest supplier and consumption market due to the highly developed pharmaceuticals technology and increased awareness of the threat of global terror activity. In 2015, USA enjoyed over 80% consumption market. 
By type, Anthrax defense products are most used with market share over 40%, followed by Smallpox defense products and Botulism defense products separately with market share about 30% and 14%. In addition, other diseases like Ebola and Marburg are occupying more and more market share. 
In this year, the international situation is not complex, and partial conflict is frequent. Terrorist organization like IS was just making terrorist activity in Paris, which largely increased people’s awareness of the threat of terrorist activity. As a result, the biodefense industry is expecting in the next years. 

The major manufacturers covered in this report 
Emergent Biosolutions 
Hytest 
GSK 
Sanofi 
PharmAthene 
Bavarian Nordic 
SIGA Technologies 
Arbutus Biopharma 
DynPort Vaccine 
Xoma Corporation 
Ichor Medical Systems 
Aeolus Pharmaceuticals 
Achaogen 
Elusys Therapeutics 
Dynavax Technologies 
Cleveland BioLabs 
Soligenix 
Alnylam Pharmaceuticals

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3217956-global-biodefense-market-research-report-2018

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering 
North America 
Europe 
China 
Japan 
Southeast Asia 
India

We can also provide the customized separate regional or country-level reports, for the following regions: 
North America 
United States 
Canada 
Mexico 
Asia-Pacific 
China 
India 
Japan 
South Korea 
Australia 
Indonesia 
Singapore 
Rest of Asia-Pacific 
Europe 
Germany 
France 
UK 
Italy 
Spain 
Russia 
Rest of Europe 
Central & South America 
Brazil 
Argentina 
Rest of South America 
Middle East & Africa 
Saudi Arabia 
Turkey 
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into 
Anthrax 
Smallpox 
Botulism 
Radiation/Nuclear 
Others 

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including 
US Military Market 
US Civilian Market 
Non - US Market

Key Stakeholders 
Biodefense Manufacturers 
Biodefense Distributors/Traders/Wholesalers 
Biodefense Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/3217956-global-biodefense-market-research-report-2018

Major Key Points in Table of Content:

Global Biodefense Market Research Report 2018 
1 Biodefense Market Overview 
1.1 Product Overview and Scope of Biodefense 
1.2 Biodefense Segment by Type (Product Category) 
1.2.1 Global Biodefense Production and CAGR (%) Comparison by Type (Product Category)(2013-2025) 
1.2.2 Global Biodefense Production Market Share by Type (Product Category) in 2017 
1.2.3 Anthrax 
1.2.4 Smallpox 
1.2.5 Botulism 
1.2.6 Radiation/Nuclear 
1.2.7 Others 
1.3 Global Biodefense Segment by Application 
1.3.1 Biodefense Consumption (Sales) Comparison by Application (2013-2025) 
1.3.2 US Military Market 
1.3.3 US Civilian Market 
1.3.4 Non - US Market 
1.4 Global Biodefense Market by Region (2013-2025) 
1.4.1 Global Biodefense Market Size (Value) and CAGR (%) Comparison by Region (2013-2025) 
1.4.2 North America Status and Prospect (2013-2025) 
1.4.3 Europe Status and Prospect (2013-2025) 
1.4.4 China Status and Prospect (2013-2025) 
1.4.5 Japan Status and Prospect (2013-2025) 
1.4.6 Southeast Asia Status and Prospect (2013-2025) 
1.4.7 India Status and Prospect (2013-2025) 
1.5 Global Market Size (Value) of Biodefense (2013-2025) 
1.5.1 Global Biodefense Revenue Status and Outlook (2013-2025) 
1.5.2 Global Biodefense Capacity, Production Status and Outlook (2013-2025)

….

7 Global Biodefense Manufacturers Profiles/Analysis 
7.1 Emergent Biosolutions 
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.1.2 Biodefense Product Category, Application and Specification 
7.1.2.1 Product A 
7.1.2.2 Product B 
7.1.3 Emergent Biosolutions Biodefense Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.1.4 Main Business/Business Overview 
7.2 Hytest 
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.2.2 Biodefense Product Category, Application and Specification 
7.2.2.1 Product A 
7.2.2.2 Product B 
7.2.3 Hytest Biodefense Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.2.4 Main Business/Business Overview 
7.3 GSK 
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.3.2 Biodefense Product Category, Application and Specification 
7.3.2.1 Product A 
7.3.2.2 Product B 
7.3.3 GSK Biodefense Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.3.4 Main Business/Business Overview 
7.4 Sanofi 
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.4.2 Biodefense Product Category, Application and Specification 
7.4.2.1 Product A 
7.4.2.2 Product B 
7.4.3 Sanofi Biodefense Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.4.4 Main Business/Business Overview 
7.5 PharmAthene 
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.5.2 Biodefense Product Category, Application and Specification 
7.5.2.1 Product A 
7.5.2.2 Product B 
7.5.3 PharmAthene Biodefense Capacity, Production, Revenue, Price and Gross Margin (2015-2018) 
7.5.4 Main Business/Business Overview 

Continued….

Contact Us:

NORAH TRENT               

Ph: +1-646-845-9349 (US)  

Sales@Wiseguyreports.Com

Ph: +44 208 133 9349 (UK)